The deadline for BC patients to transition from certain biologic to biosimilar drugs is in 30 days (November 25th, 2019).  Here’s what this means for you.

Many patients currently taking a biologic medication, a classification of biologically active medicine prescribed for various conditions like arthritis, colitis or diabetes, may be required to change their drug treatment to the biosimilar equivalent option*.  This is a cost-savings measure taken by the BC Government— and is a change that could potentially expand treatment options for some, while taking freedom of choice away from others.

*This change affects specific medications at this time.

How have you been affected by this change?

CARP wants to hear from you. Have you or a loved one already switched your medication?  Has this been a simple process?  How has it affected your treatment?  Have you experienced other impacts?

Any information shared will help to inform CARP’s work to ensure that governments employ an age-aware approach to policy, programs and funding for all elements of the health care continuum: preventive, acute, chronic, long-term and end-of-life care.